
"Breakthrough Malaria Vaccine Shows Promise in Africa"
A new malaria vaccine, RTS,S, is being rolled out in West Africa, with a 75 percent efficacy rate, while a second vaccine, R21, was approved by the WHO in December. Malaria is the second-biggest cause of death for children in Africa, with nearly all of the 200 million annual cases occurring in African countries. Factors such as weather patterns, poor sanitation, and weak healthcare systems contribute to Africa's vulnerability to malaria. While three African countries have successfully eliminated malaria, billionaire philanthropist Bill Gates predicts global eradication by 2040, but emphasizes the need for a multi-faceted approach including vaccines, insecticide sprays, and genetically modified mosquitoes. Supply and social challenges may hinder the rollout of the vaccines in African countries.

